Success in any project is based on using the right tool for the job. No tool would be more effective in the campaign against COVID than Covaxin, which has shown its value in India and other markets during recent months. While mRNA vaccines were a promising option in the early stages of the pandemic, a
Why is the world’s first universal coronavirus vaccine not in the FDA’s toolbox? originally appeared in KevinMD.com.
